Synthetic tetrapeptide bioregulator (aging research)
Epithalon
A tetrapeptide studied for telomerase and circadian effects in limited research; human evidence remains sparse and contested.
- Evidence:
- Insufficient evidence summarized
- Status:
- Research-stage
- Reviewed:
- 2026-08-03
Also known as: Epithalon, AEDG peptide, Epithalamin synthetic analog
What is Epithalon?
A tetrapeptide studied for telomerase and circadian effects in limited research; human evidence remains sparse and contested.
This profile is educational. It organizes publicly discussed research context for Epithalon and related naming aliases — it is not a treatment guide.
Proposed mechanism
Proposed telomerase activation via hTERT upregulation and pineal gland/pineal peptide signaling affecting melatonin and circadian rhythms.
Mechanism language on PepGuide describes how researchers discuss pathways. Proposed mechanisms can change as evidence evolves.
Current research notes
Human evidence grade: Insufficient evidence summarized
Preclinical evidence grade: Early-stage human research
Epitalon derives from Khavinson bioregulator research. Russian studies reported telomere lengthening and lifespan effects; independent Western replication is limited. Researchers debate methodological quality. Human evidence remains limited. Often marketed for anti-aging without robust clinical validation.
Key uncertainties
- Telomere effects in independent trials
- Safety of telomerase modulation
Research areas being studied
- Aging research
- Telomere biology
- Circadian/pineal research
Being studied for a topic is not the same as proven benefit in that topic. Prefer primary literature for study design, endpoints, and limitations.
Safety & side-effect notes
Reported or discussed adverse effects
- Insufficient systematic human data
Additional risks & considerations
- Unproven anti-aging claims
- Telomerase and cancer theoretical concerns
- Unregulated products
Regulatory status
Research-stage
Regulatory framing here is educational and can lag policy changes. Check official sources for current status.
Frequently asked questions
What is Epithalon?
A tetrapeptide studied for telomerase and circadian effects in limited research; human evidence remains sparse and contested.
How does Epithalon work (proposed mechanism)?
Proposed telomerase activation via hTERT upregulation and pineal gland/pineal peptide signaling affecting melatonin and circadian rhythms.
What is Epithalon being researched for?
Epithalon has been discussed in research contexts including: Aging research, Telomere biology, Circadian/pineal research.
What does current evidence say about Epithalon?
Insufficient evidence summarized. Epitalon derives from Khavinson bioregulator research. Russian studies reported telomere lengthening and lifespan effects; independent Western replication is limited. Researchers debate methodological quality. Human evidence remains limited. Often marketed for anti-aging without robust clinical validation.
What safety considerations are noted for Epithalon?
Reported or discussed considerations include: Insufficient systematic human data; Unproven anti-aging claims; Telomerase and cancer theoretical concerns; Unregulated products. This is educational information, not medical advice.
References & sources
- Khavinson VK et al. (2003). Peptide Epitalon and telomere maintenance research — Bull Exp Biol Med. Evidence type: animal.
Prefer interactive tools? Open the PepGuide library entry for Epithalon or ask PepGuide AI.
Educational and research information only. PepGuide does not sell or prescribe peptides, diagnose conditions, or provide personalized medical advice. Evidence summaries may include early-stage, animal, or limited human research — none of that is a substitute for primary literature or clinician guidance.